Using single cell RNA sequencing and Cancer Genome Atlas data of 179 AML patients, Galen et al. found that higher expression of CD206+ was correlated with poor survival offering CD206 as a good target in AML [72]. Here, MRC1 is linked to acute myeloid leukemia.